Vicarious Surgical (NYSE:RBOT) PT Lowered to $5.00

Vicarious Surgical (NYSE:RBOTGet Rating) had its price target lowered by Piper Sandler from $7.00 to $5.00 in a research note published on Tuesday, The Fly reports.

Separately, Zacks Investment Research downgraded Vicarious Surgical from a hold rating to a sell rating in a research note on Thursday, May 5th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of Buy and a consensus price target of $11.63.

Vicarious Surgical stock opened at $3.93 on Tuesday. The stock has a 50 day moving average of $4.70 and a 200-day moving average of $7.63. Vicarious Surgical has a 52 week low of $3.05 and a 52 week high of $15.79.

Vicarious Surgical (NYSE:RBOTGet Rating) last issued its earnings results on Thursday, March 3rd. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.04). As a group, analysts forecast that Vicarious Surgical will post -0.57 earnings per share for the current year.

In other Vicarious Surgical news, CTO Sammy Khalifa sold 6,830 shares of the business’s stock in a transaction on Thursday, April 14th. The stock was sold at an average price of $4.08, for a total value of $27,866.40. Following the transaction, the chief technology officer now owns 136,413 shares of the company’s stock, valued at $556,565.04. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Adam David Sachs sold 8,537 shares of the business’s stock in a transaction on Monday, March 28th. The stock was sold at an average price of $4.23, for a total value of $36,111.51. The disclosure for this sale can be found here. In the last ninety days, insiders sold 35,842 shares of company stock worth $152,359.

Hedge funds have recently added to or reduced their stakes in the company. Nauset Wealth Management. LLC bought a new stake in shares of Vicarious Surgical during the first quarter worth $26,000. Advisor Group Holdings Inc. bought a new stake in shares of Vicarious Surgical during the third quarter worth $27,000. BlackRock Inc. bought a new stake in shares of Vicarious Surgical during the third quarter worth $32,000. Citigroup Inc. bought a new stake in shares of Vicarious Surgical during the fourth quarter worth $47,000. Finally, Wolverine Asset Management LLC raised its position in shares of Vicarious Surgical by 165.7% during the first quarter. Wolverine Asset Management LLC now owns 10,147 shares of the company’s stock worth $51,000 after acquiring an additional 6,328 shares during the last quarter. Institutional investors own 35.25% of the company’s stock.

Vicarious Surgical Company Profile (Get Rating)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Featured Stories

The Fly logo

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.